- UBS raises Lockheed Martin's target price to $692
- Several banks launch limited-time savings gold offers to accelerate precious metals business transformation
- US Stock Alert: LKQ plunges on October 23; Q3 performance misses expectations, guidance withdrawn, Europe slowdown
- US Stock Market Movement: Credo Technology Plunges on October 23 as Directors Reduce Holdings and US Stocks Open Lower
- US Stocks Movement: Moderna Plummeted on October 23 Due to Vaccine Data Leak, Lower Efficacy Expectations, and Bearish Outlook from Investment Banks
- US Stock Market Activity: Tango Therapeutics plummets on October 23 as remission rates decline, positive news is fulfilled, and valuation adjusts
- U.S. Stocks Move: Infosys plunges on October 23 as Q2 earnings miss expectations and revenue guidance is lowered
- US Stocks Alert: Sterling Plummeted on October 23 – Data Center Infrastructure Stocks Slumped and Pre-Earnings Pullback
- BUZZ - Broker's View: Analysts are optimistic about Newmont's earnings, but caution on Red Chris project costs
- NASDAQ TRADE HALT CONTINUES <TJGC.O> REASON NOT AVAILABLE AT 09:40 AM
- NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:40 AM
- US Stock Market Moves: ITG surged on October 23 — Q3 revenue exceeded guidance, revenue increased by 49%, and digital infrastructure.
- US stock surge: Crown Castle jumps on October 23 as SpaceX negotiates for 80,000 cellular sites and communication towers
- [U.S. Stock Market Movement] Bloom Energy sharply fell on October 23: Negative cash flow + Target price downgraded + Decline in AI-related stocks
- US Stock Movements: Selective Insurance surges on October 23—EPS beats expectations, dividend increase, $200 million buyback, and property insurance
- U.S. Stocks Volatile: SoFi Plummeted on October 23 as Q3 Turned to Loss, Full-Year Guidance Lowered, and Net Write-Offs Increased
- [US Stock Market Move] Flagstar Bank Plummets on October 23: Q3 Results Miss Estimates, Provision Increases, and Deposit Competition Intensifies
- U.S. Stock Alert: Deckers Outdoor Plunges on October 23rd Due to Lowered Sales Guidance, Revenue Miss, and Downgraded Ratings
- US Stock Movement: Kinsale Capital Plunged on October 23 Due to Revenue Miss, Property Insurance Competition, and CFO Retirement
- Landmark Bancorp Publishes Update to Financial Calendar
- NASDAQ TRADE HALT CONTINUES <UCFI.O> REASON NOT AVAILABLE AT 09:39 AM
- NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM
- Bristol-Myers Squibb Leads $237 Million Series E Financing Round for Pathos AI
- Moody's French rating review is imminent; four scenarios weigh on the Euro
- Supply shocks weaken stock-bond diversification, Goldman Sachs optimistic about commodities as a hedge
- James Wynn Returns After 49 Days — Opens 40x BTC Short on Hyperliquid
- Significant regional disparities in UK housing prices: the price gap between the most expensive and most affordable areas exceeds £1 million.
- NASDAQ TRADE HALT CONTINUES <UCFI.O> REASON NOT AVAILABLE AT 09:36 AM
- Newegg Offers Nvidia RTX Spark Laptops in US, Canada
- Update: Flagstar Bank Shares Fall After Q3 Results Miss Estimates
- Ultra Jaya Milk Industry & Trading Announces Extraordinary Shareholders Meeting
- NASDAQ TRADE HALT CONTINUES <TJGC.O> REASON NOT AVAILABLE AT 09:35 AM
- Pacific Century Regional Developments completes sale of 49.87% stake in KSH Distriparks
- JBS Updates Financial Calendar
- IRSA Names Gastón Roberto Kaplan as Alternate Director Through June 2028
- Belden Collaborates With Radiflow for Automated Security Enforcement in Operational Technology Environments
- Lamor plans share issue of at least EUR 5 million as part of debt restructuring
- Oregon Bancorp Q3 net income rises from prior quarter
- Lamor seeks shareholder approval for directed share issue of at least EUR 5 million
- Bitcoin faces quantum risks by 2030 – Can developers secure BTC in time?
- DARLING INGREDIENTS INC. <DAR.N>: JP MORGAN CUTS TARGET PRICE TO $80 FROM $83
- STRIDE INC <LRN.N>: BARRINGTON RESEARCH CUTS TARGET PRICE TO $115 FROM $125
- LKQ withdraws its 2026 performance guidance and appoints a new CEO amid sluggish European market conditions
- Ai Okto Agrees to Sell Dream Arrax LPG Carrier for $18 Million
- THE BOSTON BEER COMPANY, INC. <SAM.N>: JEFFERIES RAISES TARGET PRICE TO $200 FROM $185
- PayPoint Awards Matching Shares to Executives Under Share Incentive Plan
- NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:31 AM
- NASDAQ TRADE HALT CONTINUES <TJGC.O> REASON NOT AVAILABLE AT 09:31 AM
- Mexican Peso: Stays under pressure as Banxico lags Fed – ING
- NASDAQ TRADE HALT <TGRZ.O> VOLATILITY TRADING PAUSE AT 09:30 AM
- NASDAQ TRADE HALT CONTINUES <UCFI.O> REASON NOT AVAILABLE AT 09:30 AM
- BRIEF-Toronto Stock Exchange falls at open
- Leverage Shares issues USD 650,000 in collateralized exchange-traded notes
- Bath & Body Works Opens First Feel Good Concept Store
- --Simpson Manufacturing Keeps Quarterly Dividend at $0.30 a Share, Payable Jan. 28 to Shareholders of Record as of Jan. 7
- RINGCENTRAL, INC. <RNG.N>: UBS RAISES TARGET PRICE TO $105 FROM $45
- ROLLINS INC <ROL.N>: UBS RAISES TARGET PRICE TO $37 FROM $36
- THE BOSTON BEER COMPANY, INC. <SAM.N>: UBS RAISES TARGET PRICE TO $204 FROM $190
- VALLEY NATIONAL BANCORP <VLY.O>: UBS RAISES TARGET PRICE TO $16 FROM $15
- DYNATRACE, INC <DT.N>: UBS RAISES TARGET PRICE TO $80 FROM $74
- FEMSA <FEMSAUBD.MX>: UBS RAISES TARGET PRICE TO MXN 247 FROM MXN 235
- LOCKHEED MARTIN CORPORATION <LMT.N>: UBS RAISES TARGET PRICE TO $692 FROM $653
- SOUTHWEST AIRLINES CO <LUV.N>: UBS RAISES TARGET PRICE TO $54 FROM $52
- MEDPACE HOLDINGS, INC. <MEDP.O>: UBS RAISES TARGET PRICE TO $700 FROM $673
- MOLINA HEALTHCARE INC <MOH.N>: UBS RAISES TARGET PRICE TO $225 FROM $202
- NVR, INC. <NVR.N>: UBS RAISES TARGET PRICE TO $7425 FROM $7400
- DOW INC. <DOW.N>: UBS RAISES TARGET PRICE TO $33 FROM $30
- BLACKSTONE INC. <BX.N>: UBS RAISES TARGET PRICE TO $118 FROM $116
- CHEESECAKE FACTORY INC <CAKE.O>: UBS RAISES TARGET PRICE TO $80 FROM $60
- APPFOLIO, INC. : UBS RAISES TARGET PRICE TO $240 FROM $220
- Ai Okto Declares Special Dividend of $3.50 Per Share
- --Tompkins Financial Raises Quarterly Dividend to $0.74 a Share From $0.70; Payable Nov. 13 to Holders of Record Nov. 6
- Sector Update: Energy Stocks Rise Premarket Friday
- UWM Reports Q3 Preliminary Revenue, Lowers 2026 Revenue Guidance
- Oregon Bancorp 3Q EPS 30c >ORBN
- Kenorland Minerals to Raise up to CA$11 Million in a Non-Brokered Private Placement of Shares
- EPH Group Secures Prospectus Approval for Secured Bond Offering of Up to EUR 50 Million
- i2S H1 2026 Net Loss Narrows 43% to EUR 190,765
- BlackRock raises total voting rights in LEG Immobilien to 11.39% from 11.36%
- ZoomInfo Launches Native Integration With Exa
- BRIEF-Oregon Bancorp Q3 Net Interest Income USD 4.566 Million
- Oregon Bancorp Q3 net income falls 35% year over year to $746,000
- American Express Reportedly Plans to Cut 5% of its Global Workforce
- Bolt Biotherapeutics Following Transaction, Prana Co-Founder and Former CEO Sheila Gujrathi Will Join Bolt's Executive Team and Bolt's Bd of Directors >BOLT
- Sector Update: Financial Stocks Decline Pre-Bell Friday
- Bolt Biotherapeutics: Acquisition Was Structured as a Sign-And-Close Reverse Merger >BOLT
- PRF Technologies Plans Standalone GridFeed Subsidiary to Pursue AI Energy Growth
- Indofood CBP Plans Share Buyback Amid Significant Market Volatility
- XBiotech Elects Jan-Paul Simard to Serve as Co-CEO Alongside CEO Sushma Shivaswamy >XBIT
- Alpha Metallurgical Resources Reports Preliminary Q3 Loss
- Tompkins Financial Q3 Earnings, Revenue Rise
- XBiotech Names Jan-Paul Simard Co-CEO Alongside Sushma Shivaswamy
- Lassonde Announces Third-Quarter Results Conference Call
- Celcuity reports 15.7-month median radiographic progression-free survival with drug combination in prostate cancer patients previously treated with abiraterone
- NASDAQ TRADE HALT CONTINUES <UCFIW.O> REASON NOT AVAILABLE AT 09:16 AM
- Sumber Global Energy Bonds Mature Oct. 25, 2026
- Eikon Therapeutics Reports 26.4% Response Rate for EIK1003-Paclitaxel Combination in Phase 1/2 Trial
- ISEC Healthcare 3Q2026 net profit falls 18% to S$3.21 million
- MacroGenics Reports 27% Response Rate for MGC026 in Phase 1 Head and Neck Cancer Trial
- Faeth Therapeutics Reports PIKTOR Matches or Exceeds Gedatolisib in Preclinical Breast Cancer Models
